ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq: ICUI) develops, manufactures and sells medical products for infusion therapy, vascular access and vital care, serving acute care hospitals, wholesalers, ambulatory clinics and alternate-site providers worldwide. Its portfolio includes infusion pumps, administration sets, needlefree… From the company’s description.
Over the twelve months to Sep 30, 2026, ICU Medical, Inc. reported revenue of $2.18B, down 5.9% from a year earlier, and net income of $60.33M. Its operating margin was 5.1%, and operations generated $279.24M in cash. In fiscal 2025, it reported revenue of $2.23B, down 6.3% from fiscal 2024, and net income of $0.73M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ICU Medical, Inc. does
In the company’s own words
ICU Medical, Inc. (Nasdaq: ICUI) develops, manufactures and sells medical products for infusion therapy, vascular access and vital care, serving acute care hospitals, wholesalers, ambulatory clinics and alternate-site providers worldwide. Its portfolio includes infusion pumps, administration sets, needlefree connectors, IV catheters, medication-safety software, closed-system transfer devices for hazardous drugs, and respiratory, anesthesia, patient-monitoring and temperature-management products. Key brands include Plum, CADD, Medfusion, Clave, ChemoLock, Jelco, Portex and Level 1. The company sells through its own sales force and independent distributors, reaching customers in more than 100 countries. Its IV Solutions product line is operated through a joint venture in which ICU Medical retained a 40% ownership interest after selling a controlling stake to Otsuka Pharmaceutical Factory in 2025; ICU Medical continues to sell and distribute those products. Acquisitions expanded the business, notably the 2022 purchase of Smiths Medical, which added infusion devices, vascular access and vital-care products.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- SAN CLEMENTE, CA
- Fiscal year end
- December
- CIK
- 883984
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ICU Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · ICU Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ICU Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ICU Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ICU Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”